What You Should Know:
– PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution.
– The funding was led by AVANT BIO, with participation from Barco NV and Modi Ventures. The funds will be used to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial functions, and accelerate the achievement of regulatory milestones.
PathPresenter: Revolutionizing Global Pathology Through Innovative Digital Solutions
PathPresenter is a global leader in image sharing for pathology, dedicated to democratizing access to pathology knowledge worldwide. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter aims to connect pathologists with the extensive expertise of their global colleagues and provide access to top-tier AI models.
Initially launched as a free online platform for pathology education, PathPresenter quickly grew into the world’s largest and fastest-growing digital pathology community, boasting over 50,000 users across 172 countries. The platform’s success led to the development of a secure and scalable enterprise solution, extending its applications to include clinical care, remote consultations, and research.
Today, PathPresenter’s enterprise platform is adopted by more than 50 leading hospitals, laboratories, and pharmaceutical companies. Its vendor-agnostic design supports the creation of seamless and powerful digital pathology workflows, facilitating global collaboration among pathologists. The platform incorporates advanced artificial intelligence (AI) algorithms and foundational models, aiming to enhance patient outcomes and generate new revenue opportunities from digital pathology investments.
By partnering with visionary third-party vendors, PathPresenter offers the most comprehensive and interoperable pathology workflow solution available, positioning itself as a crucial tool for clinical care, education, and research in the field of pathology.
Imogen Fitt, Senior Market Analyst, Signify Research – “The ability to select multiple vendor products and exchange information between them, known as interoperability, is crucial in today’s digital pathology landscape as customers increasingly want the freedom to select multiple ‘best-of-breed’ scanners, workflow software and AI solutions. By establishing a standards-based, open environment that offers labs choice and ensures tight integration, vendors will help overcome one of the leading barriers to user adoption, while also entrenching deeper into customer workflows. This approach will drive the next phase of digital pathology.”
